A

Achilles Therapeutics plc
D

ACHL

1.05500
USD
-0.02
(-1.40%)
Market Closed
Volume
400
EPS
-1
Div Yield
-
P/E
-1
Market Cap
43,347,736
OverviewSignalsIdeasNews
Related Instruments
    AMGN
    AMGN
    -12.22
    (-4.13%)
    280.01 USD
    E
    EGRX
    0
    (0%)
    0.000000 USD
    H
    HZNP
    0
    (0%)
    0.000000 USD
    JNJ
    JNJ
    2.140
    (1.41%)
    154.520 USD
    LLY
    LLY
    -40.34
    (-5.13%)
    789.25 USD
    MRK
    MRK
    -2.050
    (-2.08%)
    101.620 USD
    PFE
    PFE
    -1.225
    (-4.71%)
    25.760 USD
    More
News

Title: Achilles Therapeutics plc

Sector: Healthcare
Industry: Biotechnology
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.